Erweiterte Zulassung Für MS-Medikament

DNP - Der Neurologe und Psychiater
doi 10.1007/s15202-016-1136-y
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy